Announced details
Treatment support for insomnia disorder; CBT-I (cognitive behavioral therapy for insomnia disorder)
Designed to achieve a therapeutic effect on insomnia symptoms by following the instructions prompted by the app over 9 weeks.
Approval No. 30500BZX00033000
¥24,100 (reimbursement price)
The company does not address Contract Value / Impact on Business Performance.
Company research (survey conducted in May 2026; scope: program medical devices for insomnia disorder that have received marketing approval and insurance coverage)
| Item | Details |
|---|---|
| Names of Products / Services Covered | SUSMED Insomnia Disorder App Medcle |
| Offering price | ¥24,100 (reimbursement price) |
| Launch date | 1 June 2026 (sales launch and insurance coverage; actual) |
| Applicable area | Treatment support for insomnia disorder; CBT-I (cognitive behavioral therapy for insomnia disorder) |
| Registration number and expiry date | Approval No. 30500BZX00033000 |
| Quantitative Effects | Designed to achieve a therapeutic effect on insomnia symptoms by following the instructions prompted by the app over 9 weeks. |
| Source | Company research (survey conducted in May 2026; scope: program medical devices for insomnia disorder that have received marketing approval and insurance coverage) |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide patients with insomnia disorder with content based on CBT-I as its treatment principle and support the treatment of insomnia symptoms over 9 weeks.